Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levoornidazole Sodium Chloride Injection Phase IV Safety and Effectiveness Study
CTR20132576Phase 4Completed
- Sponsor
- Nanjing Sanhome Pharmaceutical Co., Ltd.
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ornidazole in Pelviabdominal infection, Oral infections, Intra-abdominal infection (IAI), surgical site infection (SSI), anaerobic infection, sponsored by Nanjing Sanhome Pharmaceutical Co., Ltd.. Started Aug 2014; status: completed.
02
Drugs
ornidazole
03
Conditions
Pelviabdominal infectionOral infectionsIntra-abdominal infection (IAI)surgical site infection (SSI)anaerobic infection
Beyond the preview
Go deeper on CTR20132576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132576.